Outcomes of Femoropopliteal Bypass for Lifestyle-Limiting Claudication in the Endovascular Era.


Journal

The Journal of surgical research
ISSN: 1095-8673
Titre abrégé: J Surg Res
Pays: United States
ID NLM: 0376340

Informations de publication

Date de publication:
11 2022
Historique:
received: 05 01 2022
revised: 23 05 2022
accepted: 09 06 2022
pubmed: 10 7 2022
medline: 24 9 2022
entrez: 9 7 2022
Statut: ppublish

Résumé

Outcomes after femoropopliteal bypass for intermittent claudication (IC) remain unclear in the endovascular era. A multi-institutional database was retrospectively queried for all femoropopliteal bypass procedures performed between 1995 and 2020. Demographics, operative details, and outcomes were documented. A statistical analysis included Kaplan-Meier curves and Cox proportional hazards ratios (HR). A total of 282 patients underwent femoropopliteal bypass surgery for IC. Median age was 68 y (interquartile range, 61-73 y). Bypass conduits included great saphenous vein (GSV) (48.2%), prosthetic grafts (48.9%), and non-GSV autogenous grafts (2.8%). Distal bypass target was above-knee in 62.1% and below-knee in 37.9% of patients. The most common postoperative complications were wound infections (14.2%) followed by unplanned 30-d hospital readmissions (12.4%). Mortality rates were low at 0.4% (30 d) and 3.2% (1 y). Five-year primary patency rates trended highest for claudicants undergoing above-knee bypass with GSV conduit (log-rank P = 0.065). Five-year amputation-free survival rates were highest using GSV conduit regardless of distal bypass target (log-rank P = 0.017). On a multivariable analysis, age (HR 1.02 [1.00-1.04], P = 0.023) and active smoking (HR 1.48 [1.06-2.06], P = 0.021) were identified as risk factors for diminished primary graft patency. Risk factors for amputation-free survival included age (HR 1.03 [1.01-1.05], P < 0.001) and GSV conduit type (HR 0.65 [0.46-0.90], P = 0.011). Femoropopliteal bypass among claudicants is associated with high rates of wound infection and hospital readmission. Active smoking portends worse outcomes in this population. These data may inform clinical decision-making regarding surgical intervention for claudication in the endovascular era.

Identifiants

pubmed: 35809357
pii: S0022-4804(22)00376-6
doi: 10.1016/j.jss.2022.06.021
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

323-329

Informations de copyright

Copyright © 2022 Elsevier Inc. All rights reserved.

Auteurs

Young Kim (Y)

Division of Vascular and Endovascular Surgery, Harvard Medical School, Massachusetts General Hospital, Boston, Massachusetts.

Karthik Thangappan (K)

Department of Surgery, University of Cincinnati Medical Center, Cincinnati, Ohio.

Charles S DeCarlo (CS)

Division of Vascular and Endovascular Surgery, Harvard Medical School, Massachusetts General Hospital, Boston, Massachusetts.

Samuel Jessula (S)

Division of Vascular and Endovascular Surgery, Harvard Medical School, Massachusetts General Hospital, Boston, Massachusetts.

Monica Majumdar (M)

Division of Vascular and Endovascular Surgery, Harvard Medical School, Massachusetts General Hospital, Boston, Massachusetts.

Shiv S Patel (SS)

Division of Vascular and Endovascular Surgery, Harvard Medical School, Massachusetts General Hospital, Boston, Massachusetts.

Nikolaos Zacharias (N)

Division of Vascular and Endovascular Surgery, Harvard Medical School, Massachusetts General Hospital, Boston, Massachusetts.

Abhisekh Mohapatra (A)

Division of Vascular and Endovascular Surgery, Harvard Medical School, Massachusetts General Hospital, Boston, Massachusetts.

Anahita Dua (A)

Division of Vascular and Endovascular Surgery, Harvard Medical School, Massachusetts General Hospital, Boston, Massachusetts. Electronic address: adua1@mgh.harvard.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH